Manganese Superoxide Dismutase (SOD2)-Mediated Delayed Radioprotection Induced by the Free Thiol Form of Amifostine and Tumor Necrosis Factor α
Murley, J. S., Kataoka, Y., Baker, K. L., Diamond, A. M., Morgan, W. F. and Grdina, D. J. Manganese Superoxide Dismutase (SOD2)-Mediated Delayed Radioprotection Induced by the Free Thiol Form of Amifostine and Tumor Necrosis Factor α. Radiat. Res. 167, 465–474 (2007). RKO36 cells, a subclone of RKO...
Gespeichert in:
Veröffentlicht in: | Radiation research 2007-04, Vol.167 (4), p.465-474 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 474 |
---|---|
container_issue | 4 |
container_start_page | 465 |
container_title | Radiation research |
container_volume | 167 |
creator | Murley, Jeffrey S. Kataoka, Yasushi Baker, Kenneth L. Diamond, Alan M. Morgan, William F. Grdina, David J. |
description | Murley, J. S., Kataoka, Y., Baker, K. L., Diamond, A. M., Morgan, W. F. and Grdina, D. J. Manganese Superoxide Dismutase (SOD2)-Mediated Delayed Radioprotection Induced by the Free Thiol Form of Amifostine and Tumor Necrosis Factor α. Radiat. Res. 167, 465–474 (2007). RKO36 cells, a subclone of RKO colorectal carcinoma cells that have been stably transfected with the pCMV-EGFP2Xho vector, were grown to confluence and then exposed to either the radioprotector WR-1065, i.e. the active thiol form of amifostine, for 30 min at doses of 40 μM and 4 mM or the cytokine tumor necrosis factor α (TNFα, TNFA) for 30 min at a concentration of 10 ng/ml and then washed. Total protein was isolated as a function of time up to 32 h after these treatments. Both doses of WR-1065 as well as the concentration of TNFα used were effective in elevating intracellular levels of the antioxidant protein SOD2 (also known as MnSOD) at least 15-fold over background levels as determined by Western blot analysis, while measured SOD2 activity was elevated between 5.5- and 6.9-fold. SOD2 reached a maximal level 24 h and 20 h after WR-1065 and TNFα treatments, respectively. The antioxidant proteins catalase and glutathione peroxidase (GPX) were also monitored over the 32-h period. In contrast to the robust changes observed in intracellular levels of SOD2 as a function of time after exposure of cells to WR-1065, catalase levels were elevated only 2.6-fold over background as determined by Western blot analysis, while GPX activity was unaffected by WR-1065 exposure. GPX protein levels were extremely low in cells, and analysis of GPX activity using a spectrophotometric method based on the consumption of reduced NADPH also revealed no measurable change as a function of WR-1065 or TNFα exposure. RKO36 cells either were irradiated with X rays in the presence of either 40 μM or 4 mM WR-1065 or 10 ng/ml TNFα or were irradiated 24 or 20 h later, respectively, when SOD2 protein levels were most elevated. The concentrations and exposure conditions used for WR-1065 and TNFα were not cytotoxic and had no effect on plating efficiencies or cell survival compared to untreated controls. No protection or sensitization was observed for cells irradiated in the presence of 40 μM WR-1065 or TNFα. Survival was elevated 1.90-fold for cells irradiated in the presence of 4 mM WR-1065. When RKO36 cells were irradiated with 2 Gy 24 h after 40 μM or 4 mM WR-1065 and 20 h after TNFα treatments when SOD2 levels were the mos |
doi_str_mv | 10.1667/RR0758.1 |
format | Article |
fullrecord | <record><control><sourceid>jstor_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_964680</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4138647</jstor_id><sourcerecordid>4138647</sourcerecordid><originalsourceid>FETCH-LOGICAL-b393t-9991791081683319fb1bf894bc217d152dca87e1e4361c23e7aefca692ad59a03</originalsourceid><addsrcrecordid>eNp1kM9q3DAQxkVpaDZpoQ9QinopycGpxvLqzzFku2kgaWCzPRtZGncV1tYi2dB9i75KXqTPFC0O7amnYeb7MTPfR8h7YBcghPyyWjE5VxfwisxAc1XMK1a9JjPGOC-yII_JSUqPLPcg9BtyDJIrJbSakd93pv9pekxIH8YdxvDLO6QLn7pxMHl49nC_KM-LO3TeDOjoArdmn-vKOB92MQxoBx96etO70eZ5s6fDBukyItL1xoctXYbY0dDSy863IQ2-R2p6R9djFyL9jjaG5BNdGjvk_s_TW3LUmm3Cdy_1lPxYfl1ffStu769vri5vi4ZrPhRaa5AamAKhOAfdNtC0SleNLUE6mJfOGiURsOICbMlRGmytEbo0bq4N46fk07T38FOdrM9ONjb0fTZUa1EJdWDOJubwZIrY1rvoOxP3NbD6EHw9BV9DRj9O6G5sOnT_wJekM_BhAh5TNvpXr4ArUcksf57kxofQ4_8PPQPJ_5RA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Manganese Superoxide Dismutase (SOD2)-Mediated Delayed Radioprotection Induced by the Free Thiol Form of Amifostine and Tumor Necrosis Factor α</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><source>BioOne Complete</source><creator>Murley, Jeffrey S. ; Kataoka, Yasushi ; Baker, Kenneth L. ; Diamond, Alan M. ; Morgan, William F. ; Grdina, David J.</creator><creatorcontrib>Murley, Jeffrey S. ; Kataoka, Yasushi ; Baker, Kenneth L. ; Diamond, Alan M. ; Morgan, William F. ; Grdina, David J. ; Univ. of Chicago, IL (United States)</creatorcontrib><description>Murley, J. S., Kataoka, Y., Baker, K. L., Diamond, A. M., Morgan, W. F. and Grdina, D. J. Manganese Superoxide Dismutase (SOD2)-Mediated Delayed Radioprotection Induced by the Free Thiol Form of Amifostine and Tumor Necrosis Factor α. Radiat. Res. 167, 465–474 (2007). RKO36 cells, a subclone of RKO colorectal carcinoma cells that have been stably transfected with the pCMV-EGFP2Xho vector, were grown to confluence and then exposed to either the radioprotector WR-1065, i.e. the active thiol form of amifostine, for 30 min at doses of 40 μM and 4 mM or the cytokine tumor necrosis factor α (TNFα, TNFA) for 30 min at a concentration of 10 ng/ml and then washed. Total protein was isolated as a function of time up to 32 h after these treatments. Both doses of WR-1065 as well as the concentration of TNFα used were effective in elevating intracellular levels of the antioxidant protein SOD2 (also known as MnSOD) at least 15-fold over background levels as determined by Western blot analysis, while measured SOD2 activity was elevated between 5.5- and 6.9-fold. SOD2 reached a maximal level 24 h and 20 h after WR-1065 and TNFα treatments, respectively. The antioxidant proteins catalase and glutathione peroxidase (GPX) were also monitored over the 32-h period. In contrast to the robust changes observed in intracellular levels of SOD2 as a function of time after exposure of cells to WR-1065, catalase levels were elevated only 2.6-fold over background as determined by Western blot analysis, while GPX activity was unaffected by WR-1065 exposure. GPX protein levels were extremely low in cells, and analysis of GPX activity using a spectrophotometric method based on the consumption of reduced NADPH also revealed no measurable change as a function of WR-1065 or TNFα exposure. RKO36 cells either were irradiated with X rays in the presence of either 40 μM or 4 mM WR-1065 or 10 ng/ml TNFα or were irradiated 24 or 20 h later, respectively, when SOD2 protein levels were most elevated. The concentrations and exposure conditions used for WR-1065 and TNFα were not cytotoxic and had no effect on plating efficiencies or cell survival compared to untreated controls. No protection or sensitization was observed for cells irradiated in the presence of 40 μM WR-1065 or TNFα. Survival was elevated 1.90-fold for cells irradiated in the presence of 4 mM WR-1065. When RKO36 cells were irradiated with 2 Gy 24 h after 40 μM or 4 mM WR-1065 and 20 h after TNFα treatments when SOD2 levels were the most increased, survival was elevated 1.42-, 1.48- and 1.36-fold, respectively. This increased survival represents a SOD2-mediated delayed radioprotective effect. SOD2 appears to be an important antioxidant gene whose inducible expression is an important element in adaptive cellular responses in general, and the delayed radioprotective effect in particular. It can be induced by a range of agents including cytoprotective nonprotein thiols such as WR-1065 and pleiotropic cytokines such as TNFα.</description><identifier>ISSN: 0033-7587</identifier><identifier>EISSN: 1938-5404</identifier><identifier>DOI: 10.1667/RR0758.1</identifier><identifier>PMID: 17388698</identifier><language>eng</language><publisher>United States: Radiation Research Society</publisher><subject>Amifostine - administration & dosage ; Cell Line, Tumor ; Cell lines ; Cell Survival - radiation effects ; Colorectal Neoplasms - enzymology ; Colorectal Neoplasms - pathology ; Cytokines ; Dose-Response Relationship, Drug ; Endothelial cells ; Humans ; Ionizing radiation ; Manganese ; Manganese Superoxide Dismutase ; Mercaptoethylamines - administration & dosage ; Radiation dosage ; Radiation Protection ; Radiation Tolerance ; RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT ; Radiation-Protective Agents - administration & dosage ; Regular ; Superoxide Dismutase - metabolism ; Superoxides ; Thiol-induced adaptive response ; Thiols ; Tumor Necrosis Factor Induced Adaptive Response ; Tumor Necrosis Factor-alpha - administration & dosage ; Tumor necrosis factors</subject><ispartof>Radiation research, 2007-04, Vol.167 (4), p.465-474</ispartof><rights>Radiation Research Society</rights><rights>Copyright 2007 Radiation Research Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b393t-9991791081683319fb1bf894bc217d152dca87e1e4361c23e7aefca692ad59a03</citedby><cites>FETCH-LOGICAL-b393t-9991791081683319fb1bf894bc217d152dca87e1e4361c23e7aefca692ad59a03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://bioone.org/doi/pdf/10.1667/RR0758.1$$EPDF$$P50$$Gbioone$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4138647$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,776,780,799,881,26955,27901,27902,52338,57992,58225</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17388698$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/964680$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Murley, Jeffrey S.</creatorcontrib><creatorcontrib>Kataoka, Yasushi</creatorcontrib><creatorcontrib>Baker, Kenneth L.</creatorcontrib><creatorcontrib>Diamond, Alan M.</creatorcontrib><creatorcontrib>Morgan, William F.</creatorcontrib><creatorcontrib>Grdina, David J.</creatorcontrib><creatorcontrib>Univ. of Chicago, IL (United States)</creatorcontrib><title>Manganese Superoxide Dismutase (SOD2)-Mediated Delayed Radioprotection Induced by the Free Thiol Form of Amifostine and Tumor Necrosis Factor α</title><title>Radiation research</title><addtitle>Radiat Res</addtitle><description>Murley, J. S., Kataoka, Y., Baker, K. L., Diamond, A. M., Morgan, W. F. and Grdina, D. J. Manganese Superoxide Dismutase (SOD2)-Mediated Delayed Radioprotection Induced by the Free Thiol Form of Amifostine and Tumor Necrosis Factor α. Radiat. Res. 167, 465–474 (2007). RKO36 cells, a subclone of RKO colorectal carcinoma cells that have been stably transfected with the pCMV-EGFP2Xho vector, were grown to confluence and then exposed to either the radioprotector WR-1065, i.e. the active thiol form of amifostine, for 30 min at doses of 40 μM and 4 mM or the cytokine tumor necrosis factor α (TNFα, TNFA) for 30 min at a concentration of 10 ng/ml and then washed. Total protein was isolated as a function of time up to 32 h after these treatments. Both doses of WR-1065 as well as the concentration of TNFα used were effective in elevating intracellular levels of the antioxidant protein SOD2 (also known as MnSOD) at least 15-fold over background levels as determined by Western blot analysis, while measured SOD2 activity was elevated between 5.5- and 6.9-fold. SOD2 reached a maximal level 24 h and 20 h after WR-1065 and TNFα treatments, respectively. The antioxidant proteins catalase and glutathione peroxidase (GPX) were also monitored over the 32-h period. In contrast to the robust changes observed in intracellular levels of SOD2 as a function of time after exposure of cells to WR-1065, catalase levels were elevated only 2.6-fold over background as determined by Western blot analysis, while GPX activity was unaffected by WR-1065 exposure. GPX protein levels were extremely low in cells, and analysis of GPX activity using a spectrophotometric method based on the consumption of reduced NADPH also revealed no measurable change as a function of WR-1065 or TNFα exposure. RKO36 cells either were irradiated with X rays in the presence of either 40 μM or 4 mM WR-1065 or 10 ng/ml TNFα or were irradiated 24 or 20 h later, respectively, when SOD2 protein levels were most elevated. The concentrations and exposure conditions used for WR-1065 and TNFα were not cytotoxic and had no effect on plating efficiencies or cell survival compared to untreated controls. No protection or sensitization was observed for cells irradiated in the presence of 40 μM WR-1065 or TNFα. Survival was elevated 1.90-fold for cells irradiated in the presence of 4 mM WR-1065. When RKO36 cells were irradiated with 2 Gy 24 h after 40 μM or 4 mM WR-1065 and 20 h after TNFα treatments when SOD2 levels were the most increased, survival was elevated 1.42-, 1.48- and 1.36-fold, respectively. This increased survival represents a SOD2-mediated delayed radioprotective effect. SOD2 appears to be an important antioxidant gene whose inducible expression is an important element in adaptive cellular responses in general, and the delayed radioprotective effect in particular. It can be induced by a range of agents including cytoprotective nonprotein thiols such as WR-1065 and pleiotropic cytokines such as TNFα.</description><subject>Amifostine - administration & dosage</subject><subject>Cell Line, Tumor</subject><subject>Cell lines</subject><subject>Cell Survival - radiation effects</subject><subject>Colorectal Neoplasms - enzymology</subject><subject>Colorectal Neoplasms - pathology</subject><subject>Cytokines</subject><subject>Dose-Response Relationship, Drug</subject><subject>Endothelial cells</subject><subject>Humans</subject><subject>Ionizing radiation</subject><subject>Manganese</subject><subject>Manganese Superoxide Dismutase</subject><subject>Mercaptoethylamines - administration & dosage</subject><subject>Radiation dosage</subject><subject>Radiation Protection</subject><subject>Radiation Tolerance</subject><subject>RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT</subject><subject>Radiation-Protective Agents - administration & dosage</subject><subject>Regular</subject><subject>Superoxide Dismutase - metabolism</subject><subject>Superoxides</subject><subject>Thiol-induced adaptive response</subject><subject>Thiols</subject><subject>Tumor Necrosis Factor Induced Adaptive Response</subject><subject>Tumor Necrosis Factor-alpha - administration & dosage</subject><subject>Tumor necrosis factors</subject><issn>0033-7587</issn><issn>1938-5404</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM9q3DAQxkVpaDZpoQ9QinopycGpxvLqzzFku2kgaWCzPRtZGncV1tYi2dB9i75KXqTPFC0O7amnYeb7MTPfR8h7YBcghPyyWjE5VxfwisxAc1XMK1a9JjPGOC-yII_JSUqPLPcg9BtyDJIrJbSakd93pv9pekxIH8YdxvDLO6QLn7pxMHl49nC_KM-LO3TeDOjoArdmn-vKOB92MQxoBx96etO70eZ5s6fDBukyItL1xoctXYbY0dDSy863IQ2-R2p6R9djFyL9jjaG5BNdGjvk_s_TW3LUmm3Cdy_1lPxYfl1ffStu769vri5vi4ZrPhRaa5AamAKhOAfdNtC0SleNLUE6mJfOGiURsOICbMlRGmytEbo0bq4N46fk07T38FOdrM9ONjb0fTZUa1EJdWDOJubwZIrY1rvoOxP3NbD6EHw9BV9DRj9O6G5sOnT_wJekM_BhAh5TNvpXr4ArUcksf57kxofQ4_8PPQPJ_5RA</recordid><startdate>200704</startdate><enddate>200704</enddate><creator>Murley, Jeffrey S.</creator><creator>Kataoka, Yasushi</creator><creator>Baker, Kenneth L.</creator><creator>Diamond, Alan M.</creator><creator>Morgan, William F.</creator><creator>Grdina, David J.</creator><general>Radiation Research Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>OTOTI</scope></search><sort><creationdate>200704</creationdate><title>Manganese Superoxide Dismutase (SOD2)-Mediated Delayed Radioprotection Induced by the Free Thiol Form of Amifostine and Tumor Necrosis Factor α</title><author>Murley, Jeffrey S. ; Kataoka, Yasushi ; Baker, Kenneth L. ; Diamond, Alan M. ; Morgan, William F. ; Grdina, David J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b393t-9991791081683319fb1bf894bc217d152dca87e1e4361c23e7aefca692ad59a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Amifostine - administration & dosage</topic><topic>Cell Line, Tumor</topic><topic>Cell lines</topic><topic>Cell Survival - radiation effects</topic><topic>Colorectal Neoplasms - enzymology</topic><topic>Colorectal Neoplasms - pathology</topic><topic>Cytokines</topic><topic>Dose-Response Relationship, Drug</topic><topic>Endothelial cells</topic><topic>Humans</topic><topic>Ionizing radiation</topic><topic>Manganese</topic><topic>Manganese Superoxide Dismutase</topic><topic>Mercaptoethylamines - administration & dosage</topic><topic>Radiation dosage</topic><topic>Radiation Protection</topic><topic>Radiation Tolerance</topic><topic>RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT</topic><topic>Radiation-Protective Agents - administration & dosage</topic><topic>Regular</topic><topic>Superoxide Dismutase - metabolism</topic><topic>Superoxides</topic><topic>Thiol-induced adaptive response</topic><topic>Thiols</topic><topic>Tumor Necrosis Factor Induced Adaptive Response</topic><topic>Tumor Necrosis Factor-alpha - administration & dosage</topic><topic>Tumor necrosis factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murley, Jeffrey S.</creatorcontrib><creatorcontrib>Kataoka, Yasushi</creatorcontrib><creatorcontrib>Baker, Kenneth L.</creatorcontrib><creatorcontrib>Diamond, Alan M.</creatorcontrib><creatorcontrib>Morgan, William F.</creatorcontrib><creatorcontrib>Grdina, David J.</creatorcontrib><creatorcontrib>Univ. of Chicago, IL (United States)</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>OSTI.GOV</collection><jtitle>Radiation research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murley, Jeffrey S.</au><au>Kataoka, Yasushi</au><au>Baker, Kenneth L.</au><au>Diamond, Alan M.</au><au>Morgan, William F.</au><au>Grdina, David J.</au><aucorp>Univ. of Chicago, IL (United States)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Manganese Superoxide Dismutase (SOD2)-Mediated Delayed Radioprotection Induced by the Free Thiol Form of Amifostine and Tumor Necrosis Factor α</atitle><jtitle>Radiation research</jtitle><addtitle>Radiat Res</addtitle><date>2007-04</date><risdate>2007</risdate><volume>167</volume><issue>4</issue><spage>465</spage><epage>474</epage><pages>465-474</pages><issn>0033-7587</issn><eissn>1938-5404</eissn><abstract>Murley, J. S., Kataoka, Y., Baker, K. L., Diamond, A. M., Morgan, W. F. and Grdina, D. J. Manganese Superoxide Dismutase (SOD2)-Mediated Delayed Radioprotection Induced by the Free Thiol Form of Amifostine and Tumor Necrosis Factor α. Radiat. Res. 167, 465–474 (2007). RKO36 cells, a subclone of RKO colorectal carcinoma cells that have been stably transfected with the pCMV-EGFP2Xho vector, were grown to confluence and then exposed to either the radioprotector WR-1065, i.e. the active thiol form of amifostine, for 30 min at doses of 40 μM and 4 mM or the cytokine tumor necrosis factor α (TNFα, TNFA) for 30 min at a concentration of 10 ng/ml and then washed. Total protein was isolated as a function of time up to 32 h after these treatments. Both doses of WR-1065 as well as the concentration of TNFα used were effective in elevating intracellular levels of the antioxidant protein SOD2 (also known as MnSOD) at least 15-fold over background levels as determined by Western blot analysis, while measured SOD2 activity was elevated between 5.5- and 6.9-fold. SOD2 reached a maximal level 24 h and 20 h after WR-1065 and TNFα treatments, respectively. The antioxidant proteins catalase and glutathione peroxidase (GPX) were also monitored over the 32-h period. In contrast to the robust changes observed in intracellular levels of SOD2 as a function of time after exposure of cells to WR-1065, catalase levels were elevated only 2.6-fold over background as determined by Western blot analysis, while GPX activity was unaffected by WR-1065 exposure. GPX protein levels were extremely low in cells, and analysis of GPX activity using a spectrophotometric method based on the consumption of reduced NADPH also revealed no measurable change as a function of WR-1065 or TNFα exposure. RKO36 cells either were irradiated with X rays in the presence of either 40 μM or 4 mM WR-1065 or 10 ng/ml TNFα or were irradiated 24 or 20 h later, respectively, when SOD2 protein levels were most elevated. The concentrations and exposure conditions used for WR-1065 and TNFα were not cytotoxic and had no effect on plating efficiencies or cell survival compared to untreated controls. No protection or sensitization was observed for cells irradiated in the presence of 40 μM WR-1065 or TNFα. Survival was elevated 1.90-fold for cells irradiated in the presence of 4 mM WR-1065. When RKO36 cells were irradiated with 2 Gy 24 h after 40 μM or 4 mM WR-1065 and 20 h after TNFα treatments when SOD2 levels were the most increased, survival was elevated 1.42-, 1.48- and 1.36-fold, respectively. This increased survival represents a SOD2-mediated delayed radioprotective effect. SOD2 appears to be an important antioxidant gene whose inducible expression is an important element in adaptive cellular responses in general, and the delayed radioprotective effect in particular. It can be induced by a range of agents including cytoprotective nonprotein thiols such as WR-1065 and pleiotropic cytokines such as TNFα.</abstract><cop>United States</cop><pub>Radiation Research Society</pub><pmid>17388698</pmid><doi>10.1667/RR0758.1</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0033-7587 |
ispartof | Radiation research, 2007-04, Vol.167 (4), p.465-474 |
issn | 0033-7587 1938-5404 |
language | eng |
recordid | cdi_osti_scitechconnect_964680 |
source | Jstor Complete Legacy; MEDLINE; BioOne Complete |
subjects | Amifostine - administration & dosage Cell Line, Tumor Cell lines Cell Survival - radiation effects Colorectal Neoplasms - enzymology Colorectal Neoplasms - pathology Cytokines Dose-Response Relationship, Drug Endothelial cells Humans Ionizing radiation Manganese Manganese Superoxide Dismutase Mercaptoethylamines - administration & dosage Radiation dosage Radiation Protection Radiation Tolerance RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT Radiation-Protective Agents - administration & dosage Regular Superoxide Dismutase - metabolism Superoxides Thiol-induced adaptive response Thiols Tumor Necrosis Factor Induced Adaptive Response Tumor Necrosis Factor-alpha - administration & dosage Tumor necrosis factors |
title | Manganese Superoxide Dismutase (SOD2)-Mediated Delayed Radioprotection Induced by the Free Thiol Form of Amifostine and Tumor Necrosis Factor α |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T06%3A23%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Manganese%20Superoxide%20Dismutase%20(SOD2)-Mediated%20Delayed%20Radioprotection%20Induced%20by%20the%20Free%20Thiol%20Form%20of%20Amifostine%20and%20Tumor%20Necrosis%20Factor%20%CE%B1&rft.jtitle=Radiation%20research&rft.au=Murley,%20Jeffrey%20S.&rft.aucorp=Univ.%20of%20Chicago,%20IL%20(United%20States)&rft.date=2007-04&rft.volume=167&rft.issue=4&rft.spage=465&rft.epage=474&rft.pages=465-474&rft.issn=0033-7587&rft.eissn=1938-5404&rft_id=info:doi/10.1667/RR0758.1&rft_dat=%3Cjstor_osti_%3E4138647%3C/jstor_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/17388698&rft_jstor_id=4138647&rfr_iscdi=true |